(Q38349107)

English

Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: A retrospective review

scientific article published on 09 February 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: A retrospective review (English)

1 reference

Europe PubMed Central

2 September 2017

methylprednisolone

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Allen D DeSena

1

1 reference

Europe PubMed Central

2 September 2017

Daniel K Noland

2

1 reference

Europe PubMed Central

2 September 2017

Karen Matevosyan

3

1 reference

Europe PubMed Central

2 September 2017

Kathryn King

4

1 reference

Europe PubMed Central

2 September 2017

Lauren Phillips

5

1 reference

Europe PubMed Central

2 September 2017

Sara S Qureshi

6

1 reference

Europe PubMed Central

2 September 2017

Benjamin M Greenberg

7

1 reference

Europe PubMed Central

2 September 2017

Donna Graves

8

1 reference

Europe PubMed Central

2 September 2017

publication date

9 February 2015

1 reference

Europe PubMed Central

2 September 2017

Journal of Clinical Apheresis

1 reference

Europe PubMed Central

2 September 2017

30

1 reference

Europe PubMed Central

2 September 2017

4

1 reference

Europe PubMed Central

2 September 2017

212-216

1 reference

Europe PubMed Central

2 September 2017

Anti-NMDA Receptor Encephalitis

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21363

21 January 2018

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21363

21 January 2018

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21363

21 January 2018

Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21363

21 January 2018

Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin.

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21363

21 January 2018

Adjunct therapeutic plasma exchange for anti-N-methyl-D-aspartate receptor antibody encephalitis: a case report and review of literature

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21363

21 January 2018

Therapeutic plasma exchange for the treatment of anti-NMDA receptor encephalitis.

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21363

21 January 2018

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21363

21 January 2018

Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21363

21 January 2018

Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21363

21 January 2018

Successful treatment of antiN-methyl-d-aspartate receptor limbic encephalitis in a 22-monthold child with plasmapheresis and pharmacological immunomodulation

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21363

21 January 2018

Paraneoplastic limbic encephalitis: ovarian cancer presenting as an amnesic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21363

21 January 2018

Simple and reliable determination of the modified rankin scale score in neurosurgical and neurological patients: the mRS-9Q.

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21363

21 January 2018

Identifiers

10.1002/JCA.21363

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38349107&oldid=2115400070"